secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2022-06-30T23:59:59+00:00
Accession:  0001493152-22-018233
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte VP/Controller/PAO Li Yu resigns effective June 24, 2022
----------------------------------------------------------------

- Li Yu resigned as VP, Controller, and Principal Accounting Officer effective June 24, 2022.
- Ms. Yu left to pursue other opportunities; no disagreements with the company.
- No successor has been named as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315222018233/0001493152-22-018233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315222018233/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-018233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer